SRx Health Solutions Reports $3.4 Million in Net Sales for Quarter Ending March 31, 2026

SRx Health Solutions, Inc. reported its financial results for the three and six months ended March 31, 2026, revealing a net sales figure of $3.4 million for the quarter and $6.2 million for the half-year, marking a significant shift as the company transitions from its previous operations in specialty healthcare to focus solely on its Consumer Products segment, which includes premium pet food and wellness products under the Halo brand. The company did not report any revenue in the same period last year, as it was primarily engaged in the now-discontinued operations of SRx Canada. The gross profit for the quarter was $1.3 million, resulting in a gross margin of 37%.

Operating expenses for the quarter totaled $3.1 million, leading to a loss from continuing operations of $1.8 million. This loss is attributed to the company's ongoing restructuring efforts and the costs associated with transitioning to a streamlined business model. The company also reported a net loss of $6.4 million for the quarter, which includes other expenses such as interest and changes in the fair value of digital assets. Notably, the company recognized a change in the fair value of digital assets amounting to $2.9 million during the quarter.

In terms of strategic developments, SRx Health Solutions has undergone significant organizational changes, including the discontinuation of its Canadian pharmacy and healthcare services business, which was classified as a discontinued operation. The company has also made strides in its capital structure, raising approximately $55 million through the issuance of common stock and $13.2 million from convertible preferred stock during the reporting period. The company’s cash and cash equivalents increased to $20.5 million as of March 31, 2026, compared to $1.3 million at the end of the previous fiscal year.

Operationally, the company has focused on enhancing its market presence, with sales driven by its digital, international, and brick-and-mortar channels. The company reported that two wholesale customers accounted for over 10% of total net sales, highlighting the importance of key partnerships in its revenue generation strategy. The company is also actively managing its supply chain and marketing efforts to optimize costs and improve gross margins, which may fluctuate due to inflationary pressures on raw materials and transportation costs.

Looking ahead, SRx Health Solutions aims to stabilize its operations and re-establish a growth trajectory aligned with its new business model. The management is focused on optimizing its cost structure and exploring strategic partnerships and product expansion opportunities to support long-term viability. The company remains committed to enhancing its operational efficiency and brand awareness in the competitive pet health and wellness market.